There has been an increasing emphasis in public health on the delivery of services with a strong empirical foundation. 1 This attention to evidence-based public health is manifest in the field of HIV prevention, where technology transfer efforts have recently been expanded. [2] [3] [4] [5] These efforts have focused largely on critically reviewing the HIV prevention intervention literature, identifying high quality scientific tests of interventions, summarizing the literature on effective interventions (either qualitatively or via meta-analysis), recommending these interventions to service providers, and providing some level of support to assist the service providers in adopting the science-based interventions (via supportive documentation, workshop-style training, or on-site technical assistance). [2] [3] [4] [5] [6] [7] Albeit scarce, some research has been conducted on the best method of delivering HIV prevention intervention technical assistance to service provision organizations. 8 While these technology transfer efforts are important and useful, service provision organizations-especially community-based organizations-have encountered several barriers in adopting science-based HIV prevention interventions. [8] [9] [10] These barriers include: (1) lack of financial, human, and temporal resources to deliver what tend to be relatively intensive HIV prevention interventions; (2) lack of resources to pay the enrollment incentives that characterize HIV prevention intervention trials; (3) high levels of staff turnover; (4) lack of sufficient training opportunities; and (5) lack of science-based interventions specifically focused on a particular community being served (thereby requiring adaptation of the intervention for the community at hand). [8] [9] [10] Of key importance is that service provision organizations need to decide whether they can afford a particular science-based HIV prevention intervention. [9] [10] [11] Policy makers who must allocate resources across disease areas also encounter difficulties when confronted with HIV prevention intervention literature syntheses. While they need to know if HIV prevention interventions are effective, they must also know the relative public health return on investment if funds are allocated to HIV prevention relative to some other important health area (such as cancer prevention or heart disease). 11 Policy makers who prioritize HIV prevention interventions relative to each other (e.g., through HIV prevention community planning processes) also need to know more than intervention effectiveness; they need to confront decisions about which prioritization of interventions would lead to optimal HIV prevention effectiveness. [11] [12] [13] Therefore, while technology transfer efforts on HIV prevention intervention effectiveness are important, they tend to fall short of addressing the key information needs of service provision organizations and resource allocation decision makers (both across disease areas and within HIV prevention). Some efforts to provide cost information along with intervention effectiveness information are beginning, but this is the exception rather than the rule. 14 Furthermore, although the literature on HIV prevention intervention cost-effectiveness is growing rapidly, it is not centrally incorporated in technology transfer efforts. 15, 16 This is likely due, in part, to the fact that there is no published framework for incorporating policy analytic information (including cost and cost-effectiveness analytic) in technology transfer efforts.
OBJECTIVES
The purpose of this article is to describe a framework for HIV prevention intervention technology transfer that explicitly incorporates quantitative policy analytic tools (including cost and cost-effectiveness analysis). Using quantitative policy analysis as a bridge between basic scientific information and policy and programmatic decision makers facilitates the technology transfer process by directly incorporating the information needs of these decision makers in the process. While we focus here on the transfer of HIV prevention intervention technology, the framework is presented generally and can also inform other types of technology transfer efforts.
CONCEPTUAL FRAMEWORK
The conceptual framework for the inclusion of quantitative policy analysis in HIV prevention technology transfer activities is displayed in the Figure. The leftmost box represents scientific information to be transferred. This information may well include intervention effectiveness findings, but in the most general sense may also include key data on social determinants of HIV-related disease, patterns of disease and risk behaviors, and prevention service delivery. The rightmost box represents policy and programmatic decision-making, especially regarding resource alloca-tion decisions (broadly defined) and judgments about whether to implement specific interventions in specific contexts (in particular, judgments regarding the affordability of these interventions). The long, dotted arrow at the bottom of the Figure represents the traditional technology transfer efforts to connect scientific findings with programmatic decision-making. In practice, this arrow often flows only from left to right. In the ideal practice of technology transfer, it is bi-directional, as depicted in the Figure. A bi-directional dialogue between scientific information and programmatic and policy decision-making is critical so that decision makers can reflect their information needs back to scientists.
However, scientists working on the topics listed in the leftmost box are generally not accustomed to providing their findings in a format directly suitable for input to programmatic and policy decision-making. This leads to the inclusion of the middle box in the conceptual framework. This box represents the use of the tools of quantitative policy analysis. [15] [16] [17] [18] [19] [20] [21] Examples of these analytic techniques include research synthesis and meta-analysis, 21 decision analysis, 19, 20 multi-attribute utility analysis (a decision analytic tool that incorporates consideration of multiple dimensions within one decision analysis), 20 and economic evaluation methods (including cost, cost-effectiveness-especially costutility analysis-and threshold analysis). 11, 16, 18, 19 The solid gray arrow in the Figure represents an important bi-directional dialogue between scientists and policy analysts (of course, policy analysis is a branch of science but we use the terms "scientists" and "policy analysts" distinctly here solely for ease of exposition). This dialogue fosters the conduct of research and the packaging of scientific information suitable for inclusion in policy analyses. It may require scientists to collect additional information (such as intervention costs), to reconsider collection of information of no particular policy relevance, or to modify the variables (such as assessing self-report behavior change in a format suitable for inclusion in cost-utility analyses). This dialogue may also cause policy analysts to be more aware of the breadth of scientific information available, as well as the nuances of intervention effectiveness and epidemiological context. It may also require them to confront methodological shortcomings in current policy analysis tools (e.g., confronting challenges that racial/ethnic health disparities pose for the conduct of cost-effectiveness analysis).
The Figure also shows a crosshatched, bi-directional arrow that reflects a dialogue between policy analysts and decision makers. It highlights the importance of policy analysts confronting in real time (or near real time) the actual problems facing decision makers. 22 It also supports the importance of policy analysts presenting their results in a format accessible, relevant, and intelligible to decision makers. 23 An additional advantage of this dialogue is that decision makers often face considerable uncertainty regarding the consequences of their choices, and several of the policy analytic tools include techniques for performing analyses under conditions of uncertainty. 15, [17] [18] [19] [20] 
CONCLUSIONS
The framework presented in the Figure highlights the importance of using the best quality science, packaged in a format suitable as input to actual HIV prevention decision-making. This conceptual framework is meant as a heuristic to improvement of technology transfer efforts by explicitly considering the use of policy analytic tools. It provides suggestions for the structure of technology transfer efforts, the roles of various parties in these efforts, and research agendas.
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